CDKN2C and gastric cancer: PRMT5 interacts with c-Myc and inhibits PTEN, CDKN2C (p18INK4C), CDKN1A (p21CIP1 or WAF1), CDKN1C (p57KIP2), and p63 gene expression to promote gastric cancer cell growth [126].